Drugs / 123-I AV39
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00439010 | Feb 2007 → Jan 2008 | Alzheimer disease | Molecular NeuroImaging | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 123-I AV39 | “Subjects will be asked to undergo a bolus injection of 123-I AV39.” NCT00439010 ↗ |
| Modality | Diagnostic / imaging agent | “123-I AV39 SPECT imaging as a tool to detect ß-amyloid deposition” NCT00439010 ↗ |